• Login
• Register

HARDWARE AND SOFTWARE SPECIFICATIONS NEEDED TO VIEW SITE

This course requires Windows Operating Systems (95/98, NT, 2000, ME, XP), version 5.5 browsers or higher from Microsoft or Netscape.

Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Macromedia Flash, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, and Real Networks Real One Player.

ACCREDITATION STATEMENT

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the Network for Continuing Medical Education (NCME). NCME is accredited by the ACCME to provide continuing medical education (CME) for physicians.

CREDIT DESIGNATION STATEMENT

NCME designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

DISCLOSURES

As a sponsor accredited by the ACCME, it is the policy of NCME to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity. The faculty of this CME activity disclose the following:

RESOLUTION OF CONFLICT OF INTEREST

NCME has implemented a process to resolve conflicts of interest for each CME activity. In order to help ensure content objectivity, independence, fair balance, and that the content is aligned with the interest of the public, NCME has resolved the conflict by conducting peer review.

UNAPPROVED/OFF-LABEL USE DISCLOSURE

NCME requires CME faculty to disclose to the participants:

1. When products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and

2. Any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.

Faculty may discuss information about pharmaceutical agents that is outside of FDA-approved labeling. This information is intended solely for CME and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

INTENDED AUDIENCE

This activity is being developed for cardiologists, emergency medicine physicians, hospitalists, internists, nurses, pharmacists, and other healthcare professionals who have an interest in treating patients with acute coronary syndromes.

EDUCATIONAL OBJECTIVES

• Improve door-to-treatment time for patients presenting with STEMI in hospitals without catheterization laboratories
• Institute new nomenclature (“Code 30” for lysis and “Code 90” for percutaneous coronary intervention [PCI]) to keep time-to-treatment goals top-of-mind with all team members
• Discuss fibrinolysis versus PCI as reperfusion options in STEMI, and examine the utility of strategies employing both options (eg, rescue PCI, facilitated PCI)
• Apply new data on adjunctive antithrombotic therapies for fibrinolysis and for PCI in the management of STEMI
• Implement the most current American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for STEMI in clinical practice

FINANCIAL SUPPORT

This CME activity is supported by an educational grant from sanofi-aventis U.S.

CME INQUIRIES

SPECIAL NEEDS